{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:00:43Z","timestamp":1791219643779,"version":"4.1.0"},"reference-count":53,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jagiellonian University Medical College","award":["N42\/DBS\/000213"],"award-info":[{"award-number":["N42\/DBS\/000213"]}]},{"name":"Jagiellonian University Medical College","award":["N42\/DBS\/000375"],"award-info":[{"award-number":["N42\/DBS\/000375"]}]},{"name":"Jagiellonian University Medical College","award":["U1C\/W42\/NO\/28.14"],"award-info":[{"award-number":["U1C\/W42\/NO\/28.14"]}]},{"name":"Strategic Program Excellence Initiative at Jagiellonian University","award":["N42\/DBS\/000213"],"award-info":[{"award-number":["N42\/DBS\/000213"]}]},{"name":"Strategic Program Excellence Initiative at Jagiellonian University","award":["N42\/DBS\/000375"],"award-info":[{"award-number":["N42\/DBS\/000375"]}]},{"name":"Strategic Program Excellence Initiative at Jagiellonian University","award":["U1C\/W42\/NO\/28.14"],"award-info":[{"award-number":["U1C\/W42\/NO\/28.14"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The taurine transporter (TauT, SLC6A6) is a member of the solute carrier 6 (SLC6) family, which plays multiple physiological roles. The SLC6 family is divided into four subfamilies: GABA (\u03b3-aminobutyric acid), monoamine, glycine and neutral amino acid transporters. Proteins from the GABA group, including the taurine transporter, are primarily considered therapeutic targets for treating central nervous system disorders. However, recent studies have suggested that inhibitors of SLC6A6 could also serve as anticancer agents. Overexpression of TauT has been associated with the progression of colon and gastric cancer. The pool of known ligands of this transporter is limited and the exact spatial structure of taurine transporter remains unsolved. Understanding its structure could aid in the development of novel inhibitors. Therefore, we utilized homology modelling techniques to create models of TauT. Docking studies and molecular dynamics simulations were conducted to describe protein\u2013ligand interactions. We compared the obtained information for TauT with literature data on other members of the GABA transporter group. Our in silico analysis allowed us to characterize the transporter structure and point out amino acids crucial for ligand binding: Glu406, Gly62 and Tyr138. The significance of selected residues was confirmed through structural studies of mutants. These results will aid in the development of novel taurine transporter inhibitors, which can be explored as anticancer agents.<\/jats:p>","DOI":"10.3390\/ijms25137339","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T06:28:54Z","timestamp":1720074534000},"page":"7339","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-9961","authenticated-orcid":false,"given":"Dorota","family":"Stary","sequence":"first","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland"},{"name":"Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, \u015bw. \u0141azarza 16, 31-530 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-0354","authenticated-orcid":false,"given":"Marek","family":"Bajda","sequence":"additional","affiliation":[{"name":"Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","article-title":"SLC6 transporters: Structure, function, regulation, disease association and therapeutics","volume":"34","author":"Pramod","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4020-6486-9_3","article-title":"Creatine and Creatine Kinase in Health and Disease","volume":"46","author":"Saks","year":"2007","journal-title":"Subcell. Biochem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"D1438","DOI":"10.1093\/nar\/gkad944","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2024","volume":"52","author":"SHarding","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/1673-5374.374139","article-title":"Emergence of taurine as a therapeutic agent for neurological disorders","volume":"19","author":"Jangra","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4103\/1673-5374.380820","article-title":"Taurine: A promising nutraceutic in the prevention of retinal degeneration","volume":"19","author":"Picaud","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jphs.2023.12.006","article-title":"Taurine deficiency associated with dilated cardiomyopathy and aging","volume":"154","author":"Ito","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/hmg\/ddz303","article-title":"Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency","volume":"29","author":"Ansar","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1096\/fj.201900914RR","article-title":"Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration","volume":"33","author":"Preising","year":"2019","journal-title":"FASEB J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehab030","article-title":"Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23","volume":"42","author":"Garnier","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_10","first-page":"4977","article-title":"SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chen, C., Cai, Z., Zhuo, Y., Xi, M., Lin, Z., Jiang, F., Liu, Z., Wan, Y., Zheng, Y., and Li, J. (2020). Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06776-7"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3349\/ymj.2017.58.1.27","article-title":"Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer","volume":"58","author":"Sung","year":"2017","journal-title":"Yonsei Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/bmm-2018-0256","article-title":"Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer","volume":"13","author":"Wang","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1038\/srep04852","article-title":"Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer","volume":"4","author":"Yasunaga","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12985-017-0695-7","article-title":"MiR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA","volume":"14","author":"Xia","year":"2017","journal-title":"Virol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.21037\/atm-20-5984","article-title":"SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway","volume":"9","author":"Feng","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Fan, Y., Zhou, Y., Lou, M., Gao, Z., Li, X., and Yuan, K. (2022). SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.845373"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-021-01933-7","article-title":"SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1533033820983029","DOI":"10.1177\/1533033820983029","article-title":"SLC6A8 Knockdown Suppresses the Invasion and Migration of Human Hepatocellular Carcinoma Huh-7 and Hep3B Cells","volume":"19","author":"Yuan","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eabi7511","DOI":"10.1126\/sciadv.abi7511","article-title":"Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels","volume":"7","author":"Kurth","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Stary, D., and Bajda, M. (2023). Taurine and Creatine Transporters as Potential Drug Targets in Cancer Therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043788"},{"key":"ref_22","unstructured":"(2024, May 14). Study Details|A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in 2nd Line RAS Mutant Advanced Colorectal Cancer|ClinicalTrials.gov, (n.d.), Available online: https:\/\/clinicaltrials.gov\/study\/NCT03597581?cond=ompenaclid&rank=2#more-information."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ijbiomac.2020.04.263","article-title":"Structure modeling of \u03b3-aminobutyric acid transporters\u2014Molecular basics of ligand selectivity","volume":"158","author":"Bajda","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1124\/mol.106.026120","article-title":"A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter\/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function","volume":"70","author":"Beuming","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/s41598-020-63189-z","article-title":"Studies of structural determinants of substrate binding in the Creatine Transporter (CreaT, SLC6A8) using molecular models","volume":"10","author":"Colas","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature03978","article-title":"Crystal structure of a bacterial homologue of Na+\/Cl\u2212-dependent neurotransmitter transporters","volume":"437","author":"Yamashita","year":"2005","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Joseph, D., Pidathala, S., Mallela, A.K., and Penmatsa, A. (2019). Structure and Gating Dynamics of Na+\/Cl\u2212 Coupled Neurotransmitter Transporters. Front. Mol. Biosci., 6.","DOI":"10.3389\/fmolb.2019.00080"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1248\/bpb.b13-00991","article-title":"Amino acid residues involved in the substrate specificity of TauT\/SLC6A6 for taurine and \u03b3-aminobutyric acid","volume":"37","author":"Yahara","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"ref_29","first-page":"S374","article-title":"The Concise Guide to PHARMACOLOGY 2023\/24: Transporters","volume":"180","author":"Alexander","year":"2023","journal-title":"Br. J. Pharmacol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0197-0186(89)90121-6","article-title":"Taurine uptake by glial cells in the bullfrog sympathetic ganglia","volume":"14","author":"Sakai","year":"1989","journal-title":"Neurochem. Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Scimemi, A. (2014). Structure, function, and plasticity of GABA transporters. Front. Cell Neurosci., 8.","DOI":"10.3389\/fncel.2014.00161"},{"key":"ref_32","unstructured":"(2021, October 14). UniProt, (n.d.). Available online: https:\/\/www.uniprot.org\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Bourne","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41586-022-04814-x","article-title":"Structural basis of GABA reuptake inhibition","volume":"606","author":"Motiwala","year":"2022","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cbdd.13388","article-title":"Homology modeling in drug discovery: Overview, current applications, and future perspectives","volume":"93","author":"Muhammed","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/iub.128","article-title":"Glycine transporters and synaptic function","volume":"60","author":"Zafra","year":"2008","journal-title":"IUBMB Life"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/APhysiol.99.2012.1.1","article-title":"Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules\u2014Glycine transporter type 1 and its inhibitors (Review)","volume":"99","author":"Harsing","year":"2012","journal-title":"Acta Physiol. Hung."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ijbiomac.2020.04.126","article-title":"\u03b3-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases","volume":"158","author":"Bajda","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"\u0141\u0105tka, K., and Bajda, M. (2022). Analysis of Different Binding Modes for Tiagabine within the GAT-1 Transporter. Biomolecules, 12.","DOI":"10.3390\/biom12111663"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pharep.2018.10.005","article-title":"Identification of competitive inhibitors of the human taurine transporter TauT in a human kidney cell line","volume":"71","author":"Richter","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2015.11.020","article-title":"Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells","volume":"82","author":"Rasmussen","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejps.2017.02.041","article-title":"Imidazole-4-acetic acid, a new lead structure for interaction with the taurine transporter in outer blood-retinal barrier cells","volume":"103","author":"Valembois","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kubo, Y., Ishizuka, S., Ito, T., Yoneyama, D., Akanuma, S.-I., and Hosoya, K.-I. (2022). Involvement of TauT\/SLC6A6 in Taurine Transport at the Blood\u2013Testis Barrier. Metabolites, 12.","DOI":"10.3390\/metabo12010066"},{"key":"ref_45","unstructured":"(2021, November 22). Bioinformatics Tools for Multiple Sequence Alignment < EMBL-EBI, (n.d.). Available online: https:\/\/www.ebi.ac.uk\/Tools\/msa\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/bioinformatics\/btg430","article-title":"The Jalview Java alignment editor","volume":"20","author":"Clamp","year":"2004","journal-title":"Bioinformatics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/nar\/gkr703","article-title":"OPM database and PPM web server: Resources for positioning of proteins in membranes","volume":"40","author":"Lomize","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.1166777","article-title":"A competitive inhibitor traps LeuT in an open-to-out conformation","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature12648","article-title":"Structural basis for action by diverse antidepressants on biogenic amine transporters","volume":"503","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/s41467-021-22385-9","article-title":"Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters","volume":"12","author":"Pidathala","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41586-021-03274-z","article-title":"Structural insights into the inhibition of glycine reuptake","volume":"591","author":"Shahsavar","year":"2021","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41594-023-00983-z","article-title":"Molecular basis for substrate recognition and transport of human GABA transporter GAT1","volume":"30","author":"Zhu","year":"2023","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7339\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:10:03Z","timestamp":1760109003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/13\/7339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":53,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25137339"],"URL":"https:\/\/doi.org\/10.3390\/ijms25137339","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]}}}